SCHEMBL31700808

SCHEMBL31700808

CNc1ccc(C2=CCN(C(=O)OC(C)(C)C)CC2(F)F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTPN2 P17706 1/20 0.43
▸ PTPN1 P18031 1/20 0.43
▸ PTPN6 P29350 1/20 0.43
▸ NAMPT P43490 2/20 0.42
▸ MAPT P10636 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ NPC1 O15118 2/20 0.36
▸ RAB9A P51151 2/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HTT P42858 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ USP30 Q70CQ3 1/20 0.35
▸ HDAC2 Q92769 2/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ WNT3A P56704 1/20 0.35
▸ GPR119 Q8TDV5 3/20 0.35
▸ F13A1 P00488 1/20 0.35
▸ TGM2 P21980 1/20 0.35
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24881275 0.86 NR1H2 (0.42) PTPN2PTPN1PTPN6NAMPTMAPT
SCHEMBL31510781 0.83 GPR119 (0.47) MAPTALDH1A1GPR119MEN1KMT2A
SCHEMBL29197802 0.82 ALDH1A1 (0.52) PTPN2PTPN1PTPN6NAMPTMAPT
SCHEMBL31510694 0.80 GPR119 (0.38) PTPN2PTPN1PTPN6NAMPTUSP30
SCHEMBL31342565 0.79 HDAC2 (0.36) PTPN2PTPN1PTPN6NAMPTHDAC2
SCHEMBL31342735 0.79 MEN1 (0.39) PTPN2PTPN1PTPN6NAMPTUSP30
SCHEMBL31510798 0.78 GPR119 (0.48) USP30GPR119
SCHEMBL31306775 0.78 PRMT5 (0.46) GPR119
SCHEMBL24880988 0.77 GRM5 (0.39) NAMPTMAPTGPR119MEN1KMT2A
SCHEMBL31510703 0.77 RBP4 (0.42) NAMPTALDH1A1USP30

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014147-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2026-01-15 — — US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 — — US disclosed
US-20250320205-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 — — US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 PTPN2 693/4885PTPN1 789/4885PTPN6 497/4885
US-20250320205-A1 STAT6 DEGRADERS STAT6, STAT1, STAT5B PTPN2 569/4885PTPN1 675/4885PTPN6 447/4885
US-20260014147-A1 STAT6 DEGRADERS STAT6, NCOR1, CBR1 PTPN2 423/4885PTPN1 232/4885PTPN6 411/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 PTPN2 693/4885PTPN1 789/4885PTPN6 497/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback